Acral Lentiginous Melanoma (ALM) Rates Higher in Southeast Asian Individuals than Other Asian Groups
source: unsplash.com

Acral Lentiginous Melanoma (ALM) Rates Higher in Southeast Asian Individuals than Other Asian Groups

  In the past, there has been limited research exploring the presentation of melanoma in Asian American and Pacific Islanders (AAPIs). Recent research has sought to explore this relationship and…

Continue Reading Acral Lentiginous Melanoma (ALM) Rates Higher in Southeast Asian Individuals than Other Asian Groups
Axitinib-Avelumab Combination Prompted Responses in Recurrent or Metastatic Adenoid Cystic Carcinoma (ACC)
mcmurryjulie / Pixabay

Axitinib-Avelumab Combination Prompted Responses in Recurrent or Metastatic Adenoid Cystic Carcinoma (ACC)

While the five-year survival rate for adenoid cystic carcinoma (ACC) is relatively high, this cancer has a high risk of recurrence. Therapeutic options are needed to manage this cancer and…

Continue Reading Axitinib-Avelumab Combination Prompted Responses in Recurrent or Metastatic Adenoid Cystic Carcinoma (ACC)
Scientists Identify New Treatment Strategy to Reduce Radiotherapy Side Effects in Nasopharyngeal Carcinoma
source: pixabay.com

Scientists Identify New Treatment Strategy to Reduce Radiotherapy Side Effects in Nasopharyngeal Carcinoma

  Currently, an estimated 47-50% of global nasopharyngeal carcinoma cases occur in China, with the regions of Guangdong, Guangxi and Fujian being heavily affected. There are a number of treatment…

Continue Reading Scientists Identify New Treatment Strategy to Reduce Radiotherapy Side Effects in Nasopharyngeal Carcinoma

Phase 3 Data Highlights the Benefits of Nivolumab for Urothelial Carcinoma

In August 2021, the U.S. Food and Drug Administration (FDA) approved Opdivo (nivolumab) for the adjuvant treatment of a rare form of cancer called urothelial carcinoma. More particularly, the drug…

Continue Reading Phase 3 Data Highlights the Benefits of Nivolumab for Urothelial Carcinoma
Cristian Shares His Wilms’ Tumor Story
https://pixabay.com/en/american-football-football-sports-1666276/

Cristian Shares His Wilms’ Tumor Story

If there’s one way that 11-year-old Cristian Muñoz would describe himself, it would be an athlete. Cristian has always been drawn to playing sports: the rigor, the competition, the connection…

Continue Reading Cristian Shares His Wilms’ Tumor Story
After Battling Wilms’ Tumor, Stephanie is Cancer-Free at Age 9
https://pixabay.com/en/youth-active-jump-happy-sunrise-570881/

After Battling Wilms’ Tumor, Stephanie is Cancer-Free at Age 9

Stephanie Felix knew exactly what she wanted for her ninth birthday: to ring the bill at Beverly Knight Olson Children’s Hospital and signify that she was—officially!—cancer-free. When Stephanie was seven…

Continue Reading After Battling Wilms’ Tumor, Stephanie is Cancer-Free at Age 9
Researchers have Discovered a Method for Targeting a Previously “Undruggable” Protein in Cancer
source: pixabay.com

Researchers have Discovered a Method for Targeting a Previously “Undruggable” Protein in Cancer

  Researchers have been grappling for years with the STAT5 protein as a tool to fight cancer. STAT5 is critical because it is partly responsible for the development and progression…

Continue Reading Researchers have Discovered a Method for Targeting a Previously “Undruggable” Protein in Cancer

Positive Results Available on Keytruda Combination for Gastric Cancer and GE Junction Carcinoma

There have been rising incidences of gastric cancer on a global scale. As a result, this cancer is now considered the fourth leading oncological cause of death worldwide. Gastric cancer…

Continue Reading Positive Results Available on Keytruda Combination for Gastric Cancer and GE Junction Carcinoma